Ho Jin Shin

Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae et al. · Cancer Chemotherapy and Pharmacology · 2007 · 112 citations

Medicine, Oncology, Chemotherapy +13

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

Pau Montesinos, Gail J. Roboz, Claude‐Eric Bulabois et al. · Leukemia · 2020 · 102 citations · Full text

Medicine, Oncology, Pharmacology +12

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy

Young Mi Seol, Bo Ran Kwon, Young Jin Choi et al. · Acta Oncologica · 2010 · 99 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma

Seok Jin Kim, Byung‐Soo Kim, Hyo Jin Lee et al. · Clinical Lymphoma & Myeloma · 2008 · 66 citations

Medicine, Pharmacology, Pharmacotherapy +11

Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells

Soon Chul Heo, Yang Woo Kwon, Il Ho Jang et al. · Stem Cells · 2016 · 62 citations

Medicine, Cardiology, Pharmacology +15